ConductScience.org, home

Paper24366362

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

Rumi E and 20 others. Blood, 2014. Cited by 483 papers, by iCite.

Cite this record

ConductScience Library. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Papers, record 24366362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24366362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
PubMed
Journal
Blood
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
483
iCite
Relative citation ratio, by iCite
15
iCite
Revised in PubMed
2025-05-29
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rumi EElisa
2Pietra DDaniela
3Ferretti VVirginia
4Klampfl TThorsten
5Harutyunyan ASAshot S
6Milosevic JDJelena D
7Them NCNicole C C
8Berg TTiina
9Elena CChiara
10Casetti ICIlaria C
11Milanesi CChiara
12Sant'antonio EEmanuela
13Bellini MMarta
14Fugazza EElena
15Renna MCMaria C
16Boveri EEmanuela
17Astori CCesare
18Pascutto CCristiana
19Kralovics RRobert
20Cazzola MMario

Source PubMed

See all 21 authorsDownload CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalreticulinMajor topic
Janus Kinase 2Major topic
MutationMajor topic
Thrombocythemia, EssentialMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Alleles
Cell Transformation, Neoplastic
Codon
Exons
Female
Granulocytes
Humans
Male
Middle Aged
Myeloproliferative Disorders
Polycythemia Vera
Primary Myelofibrosis
Prognosis
Receptors, Thrombopoietin
Thrombosis
Young Adult

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P 23257Austrian Science Fund FWFAustriaPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in24627549Two faces of ET: CALR and JAK2.https://conductscience.org/library/papers/24627549

Source PubMed

Download CSV of comments and corrections

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117389763The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera.Blood2007https://conductscience.org/library/papers/17389763PubMed
222898600JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.Blood2012https://conductscience.org/library/papers/22898600PubMed
321074499Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling.Cancer Cell2010https://conductscience.org/library/papers/21074499PubMed
416325696Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.Lancet2005https://conductscience.org/library/papers/16325696PubMed
512239137The World Health Organization (WHO) classification of the myeloid neoplasms.Blood2002https://conductscience.org/library/papers/12239137PubMed
623033268Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).Blood2012https://conductscience.org/library/papers/23033268PubMed
721228032Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms.Haematologica2011https://conductscience.org/library/papers/21228032PubMed
823216616Cardiovascular events and intensity of treatment in polycythemia vera.N Engl J Med2013https://conductscience.org/library/papers/23216616PubMed
919692701Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.Blood2009https://conductscience.org/library/papers/19692701PubMed
1016461300Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status.Haematologica2006https://conductscience.org/library/papers/16461300PubMed
1120631743A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.Leukemia2010https://conductscience.org/library/papers/20631743PubMed
1221205761Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.J Clin Oncol2011https://conductscience.org/library/papers/21205761PubMed
1315858187A gain-of-function mutation of JAK2 in myeloproliferative disorders.N Engl J Med2005https://conductscience.org/library/papers/15858187PubMed
1422802311Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study.J Clin Oncol2012https://conductscience.org/library/papers/22802311PubMed
1522160036Genetic and epigenetic complexity in myeloproliferative neoplasms.Hematology Am Soc Hematol Educ Program2011https://conductscience.org/library/papers/22160036PubMed
1615793561A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.Nature2005https://conductscience.org/library/papers/15793561PubMed
1722373697Calreticulin signaling in health and disease.Int J Biochem Cell Biol2012https://conductscience.org/library/papers/22373697PubMed
1818160670Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.Blood2008https://conductscience.org/library/papers/18160670PubMed
1916029446Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.Br J Haematol2005https://conductscience.org/library/papers/16029446PubMed
208516591Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data?Stat Med1993https://conductscience.org/library/papers/8516591PubMed

See all 36 referencesDownload CSV of references

Cited by260

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 483 citations.

PMIDTitleJournalYearIn PapersSource
42758401Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026.Curr Hematol Malig Rep2026https://conductscience.org/library/papers/42758401PubMed
42738297The Current Landscape of Pulmonary Hypertension in Myeloproliferative Neoplasms.Cancers (Basel)2026https://conductscience.org/library/papers/42738297PubMed
42613432Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.Leukemia2026https://conductscience.org/library/papers/42613432PubMed
42602648Adolescent and Young Adult versus Older Adult Philadelphia-Negative Myeloproliferative Neoplasms: A Single-Center Experience from the MENA Region.J Blood Med2026https://conductscience.org/library/papers/42602648PubMed
42271111NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera.Ann Hematol2026https://conductscience.org/library/papers/42271111PubMed
42245690Management of splenomegaly in patients with myelofibrosis in the era of JAK inhibitors: a comprehensive review.Front Oncol2026https://conductscience.org/library/papers/42245690PubMed
42154105Association between JAK2 mutations and thoracic aortic aneurysms in myeloproliferative neoplasms.J Thromb Thrombolysis2026https://conductscience.org/library/papers/42154105PubMed
42116396Recurrent central retinal artery occlusion as the initial manifestation of essential thrombocythemia: A case report.Medicine (Baltimore)2026https://conductscience.org/library/papers/42116396PubMed
42043737Thrombopoietin Receptor MPL in Hematopoiesis and Myeloproliferative Neoplasms: Physiological Roles and Pathogenic Mechanisms.Stem Cell Rev Rep2026https://conductscience.org/library/papers/42043737PubMed
41939250Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia.Hemasphere2026https://conductscience.org/library/papers/41939250PubMed
41857563Obesity supersizes macrophage and neutrophil activation after stroke while lipid droplets play a protective role.J Neuroinflammation2026https://conductscience.org/library/papers/41857563PubMed
41776088From essential thrombocythemia to polycythemia vera (ET-2-PV): rationale and design of a multicenter ELN study.Ann Hematol2026https://conductscience.org/library/papers/41776088PubMed
41721193Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis.Int J Hematol2026https://conductscience.org/library/papers/41721193PubMed
41589191Budd-Chiari Syndrome Secondary to Essential Thrombocythaemia Complicated by Acquired Von Willebrand Disease and Mimicking Hepatic Malignancy: A Case Report.Cureus2025https://conductscience.org/library/papers/41589191PubMed
41436639Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.Leukemia2026https://conductscience.org/library/papers/41436639PubMed
41051280Drug Repositioning of Pegbing® for Essential Thrombocythemia: Insights from PK/PD Modeling and Extrapolation.Clin Pharmacol Ther2026https://conductscience.org/library/papers/41051280PubMed
40772034Case Report: Myelodysplastic/myeloproliferative neoplasm with concurrent SF3B1, ASXL1, JAK2 and CBL mutations and <15% bone marrow ringed sideroblasts.Front Oncol2025https://conductscience.org/library/papers/40772034PubMed
40668166Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.JACC CardioOncol2025https://conductscience.org/library/papers/40668166PubMed
40625825Bleeding Complications in JAK2-Variant Essential Thrombocythemia: A Revisit in 2025.EJHaem2025https://conductscience.org/library/papers/40625825PubMed
40568201Hemoglobin-associated CALR in proximal tubule cells can be used as a biomarker for idiopathic membranous nephropathy.Front Med (Lausanne)2025https://conductscience.org/library/papers/40568201PubMed

See all 260 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
EPO2056PubTator's text mininghttps://conductscience.org/library/genes/2056NCBI Gene
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
MPL4352PubTator's text mininghttps://conductscience.org/library/genes/4352NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24366362

GET https://conductscience.org/api/papers/v1/24366362/authors?page=2